AKT1 and acute myeloid leukemia: The importance of crosstalk between SYK and PI3K-Akt-mTOR signaling is further supported by the observation that inhibition of PI3K-Akt-mTOR pathway activity enhances the effects of SYK inhibition on AML cell differentiation and viability [112,113].